Epidemiological studies suggest that ghrelin levels predict depression onset over 3 years (93) [see also (88) for a review], and successful response to antidepressant treatment is associated with a reduction in ghrelin levels (94). The gene discussed is GHRL; the disease is depressive symptom measurement.